Recently, a meta-analysis confirmed the negative prognostic value of TIM-3 expression among several tumors including lung cancer, although in the same analysis a favorable role of the TIM-3 expression was observed in other malignancies such us breast cancer and malignant pleural mesothelioma. Here, HAVCR2 is linked to breast cancer.